Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4

Neuroendocrine prostate cancer (NEPC) is becoming more prevalent as more potent androgen receptor (AR) pathway inhibitors are applied to patients with metastatic tumors. However, there are limited cell and xenograft models currently available, hindering the investigation of signal pathways involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yinan, Chen, Ruiqi, Bowden, Mary, Mo, Fan, Lin, Yen-Yi, Gleave, Martin, Collins, Colin, Dong, Xuesen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620142/
https://www.ncbi.nlm.nih.gov/pubmed/28978002
http://dx.doi.org/10.18632/oncotarget.19916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620142/
https://www.ncbi.nlm.nih.gov/pubmed/28978002
http://dx.doi.org/10.18632/oncotarget.19916

Ejemplares similares